$9.90
1.74% today
NYSE, Apr 03, 06:46 pm CET
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Evolent Health Inc Class A Stock price

$10.07
+1.30 14.82% 1M
-16.51 62.11% 6M
-1.18 10.49% YTD
-20.26 66.80% 1Y
-21.31 67.91% 3Y
+5.27 109.79% 5Y
-8.79 46.61% 10Y
NYSE, Closing price Wed, Apr 02 2025
+0.39 4.03%
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Key metrics

Market capitalization $1.17b
Enterprise Value $1.91b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.75
P/S ratio (TTM) P/S ratio 0.46
P/B ratio (TTM) P/B ratio 1.16
Revenue growth (TTM) Revenue growth 30.09%
Revenue (TTM) Revenue $2.55b
EBIT (operating result TTM) EBIT $2.43m
Free Cash Flow (TTM) Free Cash Flow $-6.13m
Cash position $163.50m
EPS (TTM) EPS $-0.81
P/E forward negative
P/S forward 0.57
EV/Sales forward 0.93
Short interest 13.57%
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Evolent Health Inc Class A forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
93%
Hold
7%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,555 2,555
30% 30%
100%
- Direct Costs 2,306 2,306
42% 42%
90%
249 249
26% 26%
10%
- Selling and Administrative Expenses 126 126
28% 28%
5%
- Research and Development Expense - -
-
-
123 123
24% 24%
5%
- Depreciation and Amortization 121 121
8% 8%
5%
EBIT (Operating Income) EBIT 2.43 2.43
92% 92%
0%
Net Profit -62 -62
45% 45%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Neutral
Seeking Alpha
about one month ago
Evolent Health, Inc. (NYSE:EVH ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Matthew Gillmor - KeyBanc Charles Rhyee - TD Cowen Andrea Alfonso - UBS Jailendra Singh - Truist Securities Ryan Daniels - Wi...
Neutral
PRNewsWire
about one month ago
Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively. Net loss attributable to common shareholders of Evolent Health, Inc. of $30.6 million for three months ended December 31, 2024 and $93.5 million for the year ended December 31, 2024, resulting in a net loss...
Neutral
PRNewsWire
about 2 months ago
Richard " Rick "  Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb ' s Appointment as New Independent Director WASHINGTON , Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to...
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,500
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today